| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4794775
Max Phase: Preclinical
Molecular Formula: C12H15N3O2
Molecular Weight: 233.27
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Oc1ccc(CNCCc2c[nH]cn2)cc1O
Standard InChI: InChI=1S/C12H15N3O2/c16-11-2-1-9(5-12(11)17)6-13-4-3-10-7-14-8-15-10/h1-2,5,7-8,13,16-17H,3-4,6H2,(H,14,15)
Standard InChI Key: LYYCHOOKQZDHHB-UHFFFAOYSA-N
Associated Targets(non-human)
Arginase-1 70 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 233.27 | Molecular Weight (Monoisotopic): 233.1164 | AlogP: 1.15 | #Rotatable Bonds: 5 |
| Polar Surface Area: 81.17 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.48 | CX Basic pKa: 8.60 | CX LogP: 0.41 | CX LogD: -0.60 |
| Aromatic Rings: 2 | Heavy Atoms: 17 | QED Weighted: 0.46 | Np Likeness Score: -0.11 |
References
| 1. Muller, J., Cardey, B., Zedet, A., Desingle, C., Grzybowski, M., Pomper, P., Foley, S., Harakat, D., Ramseyer, C., Girard, C., Pudlo, M.. (2020) Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors, 11 (5): [PMID:33479657] [10.1039/d0md00011f] |
Source
Source(1):